Wolfson medical center
Holon, Israel
NCT Number: NCT03063853
The optimal choice of skin closure at cesarean delivery has not yet been determined. This study aim to study the wound complications and scar healing after Surgical staples removal at postoperative day 4 and day 8 .
A randomized control trial.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Holon, Israel
A randomized controlled trial in which pregnant women undergoing a scheduled Elective cesarean delivery were assigned to skin closure with surgical staples and were randomly assigned to the day of removal of surgical staples. Postoperative day 4 VS. Postoperative day 8 .
Outcome assessors were blinded to group allocation. Scars will be evaluated after 8 weeks. Primary outcome measures is Patient and Observer Scar Assessment Scale (POSAS) scores. Secondary outcome measures are complications of surgical site infection (SSI) or wound disruption (hematoma or seroma).
A group of 104 women is needed in order to achieve a clinically significant effect with a power of 80%.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Removal of surgical clips at day 4 post operative vs day 8 post operative
non emergent elective cesarean delivery
Time frame: 8 weeks postoperative
Time frame: 8 weeks postoperative
Wolfson Medical Center
Other Gov
Early Versus Late Removal of Surgical Staples After Cesarean Delivery. Randomized Control Trial.
Acronym: ROCD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07256405
Bone, Fracture
Marseille, Bouches-du-Rhône, France
View Trial DetailsNCT07200401
Cardiac Surgery, Infection, Soft Tissue
Brighton, United Kingdom
View Trial DetailsNCT06092866
Digestive System Diseases, Gastro-Intestinal Disorder
Malmö, Region Skane, Sweden
View Trial DetailsNCT04872400
Anti-bacterial Agents, Extremity Fracture Lower
Aurora, Colorado, United States
View Trial Details